Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)
Clinical Feasibility and Efficacy of a New Digital Single-operator Peroral Cholangiopancreatioscopy System: a Multicenter Registry
1 other identifier
observational
N/A
1 country
5
Brief Summary
Cholangioscopy, or direct visualization of the bile ducts was first documented in the late 1970s and has made many advances over the last few decades. The advent of mother-baby scopes allowed for both diagnostic and therapeutic procedures, though the early scopes were often fragile, and cumbersome due to the need for two endoscopists. Ultraslim endoscopes later became popular as a method to digitally view the bile ducts, however, often needed guide-wire or balloon-assistance to allow for cannulation. Other disadvantages of these systems included limited steerability, and poor irrigation capabilities. The advent of Spyglass, a single-operator peroral cholangioscopy method allowed for a fiberoptic, catheter-based system that could be easily used for diagnostic and therapeutic purposes in the biliary system. However, image quality was often lacking due to the fiberoptic technology. The new digital Spyglass system rectifies this inadequacy by introducing a digital sensor for better image quality, which will allow for better visualization and diagnosis of indeterminate strictures. Furthermore, modification of the scope platform allows for efficient use, reliable directionality of the scope tip, and improved ease of passage of accessories during therapeutic procedures such clearing stones or stent placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2015
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 12, 2016
CompletedFirst Posted
Study publicly available on registry
May 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedDecember 4, 2020
December 1, 2020
2.8 years
May 12, 2016
December 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Stone clearance rate
% of complete removal of bile duct stones
6 months
Secondary Outcomes (1)
Diagnostic accuracy for indeterminate bile duct strictures
6 months
Study Arms (2)
Bile duct Stricture
Patients referred for the evaluation of indeterminate strictures.
Common bile duct Stones
Patients referred for the removal of difficult stones.
Interventions
Eligibility Criteria
Formation of a multi-site prospective database of all patients referred for the evaluation of indeterminate strictures or removal of difficult stones.
You may qualify if:
- All patients referred for the evaluation of indeterminate strictures or removal of difficult stones.
You may not qualify if:
- All patients who are unable or unwilling to give consent will not be included in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- University of Colorado, Denvercollaborator
- University of California, Los Angelescollaborator
- H. Lee Moffitt Cancer Center and Research Institutecollaborator
- University of Utahcollaborator
- Ochsner Health Systemcollaborator
Study Sites (5)
UCLA Medical Center
Los Angeles, California, 90095, United States
University of Colorado, Denver
Denver, Colorado, 80202, United States
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Ochsner Medical Center
New Orleans, Louisiana, 70121, United States
University of Utah
Salt Lake City, Utah, 84132, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Endoscopy
Study Record Dates
First Submitted
May 12, 2016
First Posted
May 18, 2016
Study Start
July 1, 2015
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
December 4, 2020
Record last verified: 2020-12